Introduction
Cardiovascular events such as stroke, sudden death and acute myocardial infarction have an increased incidence in the morning [1] [2] [3] [4] [5] and a smaller peak in the evening. The mechanisms involved in this variation in cardiovascular events are not clear, and may involve various factors such as augmented sympathetic activation, 6, 7 haemodynamic changes, 8 neurohumoral factors and increases in coagulation. 9 Impaired endothelial function and arterial stiffening are associated with increased risk for cardiovascular events. [10] [11] [12] Recent studies suggest that there is a circadian variation in endothelial function in healthy individuals, with its lowest value in the morning. 13 However, some studies imply that there might be a differentiation of the circadian variation of endothelial function in different conditions 14, 15 (for example, menopause) and diseases 16, 17 (for example, dilated cardiomyopathy, sleep apnoea), whereas others question the existence of diurnal variation in endothelial function, particularly in populations being at very high risk for cardiovascular events. 16, [18] [19] [20] [21] Thus, it appears that several factors affect the diurnal pattern of endothelial function. Moreover, a circadian variation of arterial stiffness has been demonstrated in healthy subjects indirectly by pulse wave analysis. [22] [23] However, this has not been examined in other conditions for which such variations might be more clinically relevant such as in systolic hypertension in which arterial stiffness is considered as one of its most important haemodynamic determinants. 24 Several biochemical markers affecting vascular function, such as glucose, lipids, C-reactive protein (CRP) and cortisol, present circadian variation [25] [26] [27] and may therefore be involved in or correlate to the diurnal changes of endothelial function and arterial stiffness. In particular, CRP may directly enhance the proinflammatory inducible nitric oxide synthase and inhibit the atheroprotective endothelial nitric oxide synthase 28 irrespective of its attribute as a marker of inflammation.
Hypertension is a common and well-established cardiovascular risk factor, significantly associated with increased mortality. 29 Nevertheless, the presence of diurnal variation of endothelial function and arterial stiffness in individuals with hypertension is not known. Identification of the variation of these markers, which are related with increased cardiovascular risk in hypertensive patients particularly at early stages of hypertension, could be useful in their management as some antihypertensive drugs may also improve endothelial function and arterial stiffening. [30] [31] [32] Furthermore, it could offer an insight to the mechanisms responsible for the temporal variation of cardiovascular events. We hypothesized that the circadian variation of endothelial function and arterial stiffness is preserved in newly diagnosed hypertensives at relatively low cardiovascular risk. Thus, in this study, we investigated the diurnal variation of endothelial function and arterial stiffness in individuals with hypertension.
Materials and methods
We studied 35 individuals with hypertension (14 men) recruited from the hypertension clinic of our hospital. A diagnosis of hypertension was established when systolic arterial pressure was 4140 mm Hg and/or diastolic arterial pressure was 490 mm Hg, after three blood pressure measurements in each of the two consecutive office visits, with an interval between visits of at least 4 weeks. 33 Inclusion criteria comprised recently diagnosed (o1 year) or first-diagnosed primary hypertension, age between 30 and 60 years, body mass index o35 kg m À2 , no history of cardiovascular disease and a pattern of blood pressure dipping in ambulatory blood pressure monitoring. A decrease in mean systolic and diastolic blood pressure greater than 10% during the night was defined as dipping. A serum creatinine of more than 115 mmol l À1 in men and 106 mmol l À1 in women was also considered an exclusion criterion. Structural heart disease was excluded by echocardiography. Carotid and peripheral arterial disease was excluded by vascular ultrasonography. Thirteen individuals were never treated for hypertension. In 17 individuals who were receiving antihypertensive therapy, a washout period without treatment of at least 2 weeks was allowed before they entered the study.
All subjects were asked to abstain from the use of tobacco, alcohol and caffeine for 24 h before the study. Women of reproductive age were examined during the early follicular phase of the menstrual cycle. All patients received a light standardized lunch and dinner, were asked to stay overnight in the hospital and were awakened at 0700 hours. Studies were performed in patients in the supine position in a quiet, temperature-controlled (20-23 1C) room.
Endothelial function and arterial stiffness were measured on three occasions at a random order: at noon, 4 h after breakfast (1200 hours), in the evening, before subjects went to sleep, 4 h after supper (2100 hours) and in the early morning immediately after waking, before breakfast (0700 hours). Blood samples were also taken on the same three occasions and analysed. Analysis included substances that influence endothelial function such as glucose, lipids, cortisol, hsCRP and catecholamines. All subjects were submitted in 24-h ambulatory blood pressure measurement at the same day of the vascular function evaluation, with the use of Spacelabs recorders (Spacelabs 90207; Spacelabs). Blood pressure measurements were taken automatically every 15 min during the 24-h period of the recording. Investigators involved in the analysis of vascular and biochemical parameters were blinded to the study phase. The research protocol of this study was approved by the Ethics Committee of our hospital and all subjects gave informed consent.
Blood assays
Plasma glucose was measured with an autoanalyser using the hexokinase method with intra-and interassay coefficients of variation (CVs) of 1.4 and 2.1%, respectively. Total cholesterol, triglycerides, low-density lipoprotein cholesterol and highdensity lipoprotein cholesterol were measured using standard analysers. High-sensitivity CRP was measured by immunoturbidimetric ultrasensitive determination (Sentinel Diagnostics, Milan, Italy) with intra-and interassay CVs of 0.42 and 0.97%, respectively. Cortisol was measured by immunochemoluminescence (Roche Diagnostics, Indianapolis, IN, USA) with intra-and interassay CVs of 5.2 and 6.8%, respectively. Plasma catecholamines were measured by radioimmuno assay (Dopamine Research RIA, 2cat RIA; Biosource Europe, Nivelles, Belgium). Intraassay CVs for adrenaline and noradrenaline were 12 and 4%, respectively, and interassay CVs were 6.1 and 10.1% for these hormones, respectively.
Vascular measurements
Evaluation of endothelial function. Endothelial function was evaluated by ultrasound measures of flow-mediated endothelium-dependent vasodilation (FMD) and endothelium-independent vasodilation (NMD) of the brachial artery. 34 Assessment of FMD and NMD was performed by using a 14.0-MHz multi-frequency linear array probe attached to a high-resolution ultrasound machine (Vivid 7 Pro; General Electric, GE Healthcare, Wauwatosa, WI, USA). The right brachial artery of each participant was longitudinally imaged at the antecubital fossa in a supinated position of the forearm. A continuous electrocardiogram trace was recorded for timing diastole. Subjects rested in the supine position for 10 min before each measurement. A pneumatic cuff was placed around the forearm and, after the initial measurements at resting conditions, the cuff was rapidly inflated to 250 mm Hg for 5 min. After deflation of the cuff, the increase of arterial flow (reactive hyperaemia (RH)) was monitored for 90 s and the diameter of the brachial artery was measured at 30, 60 and 90 s. FMD was calculated as the percentage maximal change of lumen diameter between baseline and RH. Next, after a 10-min resting period, a sublingual dose of nitroglycerin spray (0.4 mg) was given, and the dilatation of the brachial artery was measured at 4 min. RH was calculated as the maximum percent increase of blood flow (flow ¼ p Â (brachial artery radius) 2 Â velocity) after deflation of the cuff compared with the baseline flow (RH ¼ post-occlusion flow/baseline flow Â 100). NMD was calculated as the percentage maximal change of lumen diameter between baseline and endothelium-independent vasodilation. All subjects were scanned by a single experienced investigator (GK). The intraobserver variability of this investigator (GK) measured in a subgroup of our population on two different days at 0700 hours varied by 0.06 ± 0.86 mm and 0.9 ± 1.1% (mean ± s.d.) for brachial artery diameter and FMD (CV ¼ 8.2%), respectively.
Evaluation of arterial stiffness. Pulse wave velocity (PWV), an established index of aortic stiffness, 35 was calculated from measurements of pulse transit time and the distance travelled between two recording sites with a validated non-invasive device (Complior; Artech Medical, Pantin, France) that allows online pulse wave recording and automatic calculation of PWV (PWV equals distance (m) divided by transit time (s)). Two different pulse waves were obtained simultaneously at two sites with two transducers. PWV between common carotid artery and common femoral artery (cf) as a measure of arterial stiffness in the elastic-type arteries was assessed. cfPWV was calculated by dividing the distance separating the two sensors by the time corresponding to the period separating the start of the rising phase of the carotid pulse wave and that of the femoral pulse wave. cfPWV was expressed in m s À1 . The pulse wave propagation distance was the total distance between the carotid and femoral sites measured with a tape measure over the surface of the body. 36 The CV for PWV in a subgroup of our population measured on 2 different days at 0700 hours by the same operator (GK) was 1.2%.
Statistical analysis
Data are expressed as the mean value±s.d. unless otherwise stated. As data on diurnal variation of PWV are missing, based on previous data of morning measurements of PWV in a Greek hypertensive population, 37 we calculated that to detect a maximum change of 10% in PWV with a power of 90% and a two-tailed error probability a ¼ 0.05, a sample size of at least 32 patients was needed. Also, based on the suggestions from the International Brachial Artery Reactivity Task Force, 34 a similar number of subjects would be adequate to identify a clinically relevant change of 1.5-2% in FMD. Distribution of all parameters was assessed by the Shapiro-Wilk test, which is considered to be the most reliable test of normality for small-to-medium-sized samples (No50). 38 Parameters not normally distributed at least in one of the three recorded successive samples (hours of the day) were analysed by using the nonparametric statistical tests; Friedman for assessing overall variation among the three measurements and Wilcoxon for assessing paired comparisons between 0700 hours vs 1200 hours, 0700 hours vs 2100 hours and 1200 hours vs 2100 hours, respectively. When multiple comparisons (N ¼ 3) were performed, Bonferroni correction was applied and a P-value of 0.05/3 ¼ 0.017 was considered as statistically significant. Normally distributed parameters were analysed by analysis of variance for repeated measures with post hoc analysis (Bonferroni-corrected t-test). Circadian variation in FMD and PWV was calculated by the formulas (maximal FMDÀmi-nimal FMD)/maximal FMD Â 100 (%) and (maximal PWVÀminimal PWV)/maximal PWV Â 100 (%) for each individual separately. Adjustment of PWV variation for blood pressure changes was performed by using analysis of covariance (multivariate general linear model for repeated measurements). Data were analysed with SPSS 15.0 statistical package. A value of Pp0.05 was considered significant.
Results
The characteristics of the study population are reported in Table 1 . Vascular, haemodynamic and biochemical parameters measured on three different occasions during a 24-h period appear in Table 2 .
Haemodynamic measurements
Clinic and mean ambulatory systolic and diastolic blood pressures at 0700 hours and during the period 0600 to 0900 hours, respectively were significantly lower in comparison with blood pressures during the rest of the day (Table 2, Figure 1) . A decrease in mean systolic and diastolic blood pressure was observed in all patients during the night, greater than 10% of the respective blood pressure during the day (dippers). FMD was significantly lower at 0700 hours when compared with FMD measured at 1200 and 2100 hours (Table 2, Figure 1 ). The morning decrease in FMD was observed both in men (n ¼ 14, FMD 0700 hours: 2.1±1.9%; 1200 hours: 5.0±2.7%; 2100 hours: 4.2±2.4; P ¼ 0.004) and women (n ¼ 21, FMD 0700 hours: 2.3 ± 1.4%; 1200 hours: 3.9±1.9%; 2100 hours: 4.3±2.0%; P ¼ 0.002) when analysed separately. No significant variation of NMD, baseline diameter of the brachial artery or RH was observed between the three different measurements (Table 2) . PWVcf was progressively increased from 0700 to 2100 hours, with the highest value measured at 2100 hours (0700 vs 2100 hours, P ¼ 0.007 for multiple comparisons; Table 2 , Figure 2) . Circadian variation in FMD and PWVcf did not differ between patients not receiving and those receiving medication (no medication, 55.3±26.9 vs 66.3±30.5%, P ¼ 0.29, 15.3±9.1 vs 14.3±7.1%, respectively). The overall PWVcf variation was not significant after adjustment for changes in mean blood pressure.
Biochemical measurements
There were no significant variations in the plasma catecholamine levels at the three different occasions (measured in 25 individuals) nor in CRP serum levels ( Table 2 ). Cortisol levels were significantly higher at 0700 hours and gradually decreased at the subsequent measurements (Table 2, Figure 1 ). Glucose and triglyceride serum levels also showed significant variation across the three time points. 
Discussion
The results of this study demonstrate for the first time that endothelial function is attenuated in early morning in non-diabetic individuals with primary hypertension with or without other risk factors. Furthermore, arterial stiffness showed a different temporal pattern, with its highest value measured in the evening, which coincided with the highest blood pressure levels. These findings imply a possible relation between diurnal variation of endothelial function and arterial stiffness, with a two-peak incidence of acute coronary syndromes and stroke onset. Data on circadian variation of endothelial function in healthy subjects are not consistent, 13, 14, 18, 21 although investigating the circadian variation of endothelial function in populations at increased cardiovascular risk is more clinically relevant, as treatment according to a certain time pattern might improve strategies of primary and secondary prevention of coronary artery disease. Only few studies have addressed this issue in such groups, 15, 16, 18 whereas none has examined the circadian variation of endothelial function in hypertension. On the basis of current evidence, it seems that very-high- risk groups, such as patients with advanced heart failure and coronary artery disease, 16, 18 lose the pattern of diurnal variation of endothelial function, in contrast to others at lower risk. [15] [16] [17] Indeed, our results support this hypothesis, as circadian variation of endothelial function was preserved in a population at relatively low risk with regard to hypertension and its complications, consisting of relatively young, newly or recently diagnosed hypertensives, all dippers, and without structural heart disease or peripheral arterial disease.
The specific mechanisms responsible for the morning-related endothelial impairment in hypertensives cannot be easily identified, and it was not the primary objective of this study. The simultaneous early morning increase in serum cortisol levels might be involved in these mechanisms, 26, 39 whereas a late detrimental effect on endothelial function exerted by a combination of factors, such as increased blood pressure and triglycerides found in the evening, cannot be excluded. In regard to cortisol, an observation that argues against causality with FMD is that cortisol further decreases from noon to 2100 hours, whereas FMD remains unchanged, suggesting that cortisol changes are not linearly related with those of FMD. However, a nonlinear relationship with FMD, reaching its highest value after a threshold value of cortisol, cannot be excluded because there is both pathophysiological background for this observation 26, 39 and FMD is known to be deteriorated in hypertension. 40 The latter implies an anticipated limited response to endogenous biochemical and other stimuli, including fluctuating cortisol levels. Finally as we did not observe any diurnal alterations in inflammatory status, as assessed by CRP, such a mechanism cannot be implemented for the changes in vascular function.
Arterial stiffness variation showed a different temporal pattern as compared with endothelial function. In this population of hypertensives, arterial stiffening was more pronounced in the evening coinciding with the highest values of arterial blood pressure measured at clinic and that derived from ambulatory blood pressure monitoring. A passive distension effect of arterial blood pressure on arterial stiffness may mediate this variation, as stiffness increases at higher blood pressures due to the non-linear pressure-volume relationship in the arterial wall. 41 In agreement with this known close PWV-blood pressure coupling, our results showed that diurnal PWV changes lost significance after adjustment for BP, suggesting that changes in arterial stiffening are mediated through changes in BP. This concept may partly explain the discrepancy between temporal patterns in FMD and PWV. The possibility that a peak of morning surge in arterial blood pressure 22 may have been missed in this study should be acknowledged, because the morning measurements were performed immediately (o10 min) after awaking and therefore blood pressure may have reflected only a point in the ascending pressure curve. Finally, as previously reported in similar designs, 13 ,42 a significant variation in sympathetic activation was not observed in this study. The two-peak temporal deterioration of vascular function observed in this study grossly coincides with the observed morning and evening increased incidence of cardiovascular events. [1] [2] [3] [4] [5] Thus, variation of arterial stiffening and endothelial function may have implications for our understanding of the diurnal peaks in cardiac and vascular events. However, it should be underscored that second peaking of vascular dysfunction due to arterial stiffening may not be robustly substantiated as it most probably depends on temporal peaking of BP, which is not always observed in the evening. Indeed, despite the fact that our results could show a significant change in PWV supported by an adequate sample size, earlier studies have shown increased reflected waves in the morning, 22 ,23 a finding probably easier explained due to an often higher sympathetic activity at that time. 8 Nevertheless, in our population, arterial stiffening was directly measured by PWV, an index not always in agreement with changes in reflected waves, whereas sympathetic activity, as assessed by catecholamine levels, did not show any fluctuations.
A few limitations of this study should be acknowledged. This study did not include a non-hypertensive control group and therefore no direct comparisons are possible with the general population. As with earlier studies, due to technical difficulties and consent issues, the design of the study predicted only a small number of endothelial function tests per day. This may limit conclusions on the pathophysiological mechanisms involved in the diurnal variation of vascular function. A second limitation is that the possibility of sleep apnoea or other sleep disorders was not excluded by polysomnographic study but by a detailed past medical history. It should be also acknowledged that several subjects were on antihypertensive medication, earlier, which, however, was discontinued for a sufficient time period to assume complete elimination, whereas variation of FMD and PWV was not affected by medication. In addition, although vascular smooth muscle function assessed by NMD did not change significantly, the routinely recommended high dose of nitroglycerin 34 might mask fluctuations that might be possibly observed with a lower dose. The lack of a computerized system to assess FMD is a potential limitation. However, the CV for FMD from our laboratory is comparable with that reported by Donald et al., who measured FMD with a computerized system ranging from 6.6 to 10.6%. 8 Finally, as we examined a relatively homogeneous low-risk population, these findings cannot be generalized to hypertensive patients with a non-dipping pattern or target organ damage.
In conclusion, we have documented a two-peak deterioration of vascular function with a significant reduction of endothelial function in the morning and an evening augmentation of PWV in individuals with primary hypertension. This finding might extend the concept of chronotherapy of hypertension to further target diurnal changes of vascular function 43 as some antihypertensive drugs also improve endothelial function and arterial stiffness. [30] [31] [32] Whether drug-induced effects on the circadian rhythm of blood pressure 44 are followed by similar effects on the arterial stiffness temporal pattern is not known. 45 Further study is needed to investigate the mechanisms involved in this phenomenon and to address its implications in our understanding of the circadian variation in cardiovascular events.
